Nyxoah SA

NASDAQ:NYXH 12:59:43 AM EDT

7.77

+0.07 (+0.91%)

4:42:09 PM EDT: $7.70 -0.07 (-0.90%)

Market Cap (Intraday)	293.47M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.5 Million
Adjusted EPS	-$0.63

See more estimates

10-Day MA	$7.68
50-Day MA	$7.17
200-Day MA	$8.56

See more pivots

Nyxoah SA Stock, NASDAQ:NYXH

Rue Edouard Belin 12, Mont-Saint-Guibert, Walloon Region 1435

Belgium

Phone: +32.10.22.23.55

Number of Employees: 146.8

http://www.nyxoah.com

Description

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.